By: J. De Grève MD, PhD, L. Dirix MD, PhD, P. Vuylsteke MD, H. Wildiers MD, PhD
2011 has been a rich year in progress on cancer care. Items already mentioned last year have been confirmed in full papers and are entering daily clinical practice. This article summarises the highlights in oncology of the past year.
(BELG J MED ONCOL 2012;6:38–41)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
